For research protocols requiring isolated study of GH/IGF-1 axis effects, the CJC-1295/Ipamorelin combination provides cleaner data by eliminating cortisol and prolactin as variables
Third Party Tested Independent third party laboratories verify purity, potency, and accurate dosing to ensure the highest quality and safety standards
Lipid panel: Baseline, because GH modulates lipid metabolism
Lean mass tends to climb and visceral fat tends to fall, which is where the InBody scan becomes useful for showing real change
Bioavailability High most of the dose reaches your bloodstream, just more gradually than an IV
CJC-1295/Ipamorelin therapy is not recommended for individuals with active cancer, uncontrolled diabetes, and certain endocrine disorders